Followers | 256 |
Posts | 10098 |
Boards Moderated | 1 |
Alias Born | 07/25/2008 |

Sunday, June 08, 2025 10:18:09 PM
It has come to my attention that a user on this board has made the false and defamatory claim that I am being paid by the company to express a bullish sentiment.
Let me be absolutely clear:I am not, and have never been, compensated by the company in any way for my posts, opinions, or research.
These types of accusations are not only false—they are potentially libelous under U.S. defamation law. Publicly accusing someone of undisclosed paid stock promotion without any proof is a serious matter that can carry legal consequences, especially when done with the intent to discredit or silence differing views.
I am documenting all such defamatory posts and reserving my rights, including potential legal action. I encourage any user who values honest discussion and integrity to do the same when they are falsely accused.
This board should be a place for facts, filings, and open discourse—not reckless smears.
IMHO
GLTA
Recent RDAR News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/03/2024 09:21:58 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 11/29/2024 09:28:55 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM